AA
Allos AI
United States · AI · Healthtech · Biotech
Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies.
AI-guided drug formulation
Allos AI works with drug developers and generic manufacturers to choose formulations, delivery routes and dosing strategies. Its causal models connect chemistry and process variables with drug performance, helping teams identify which experiments will resolve a development problem.
The company combines modeling and data science with pharmaceutical specialists who coordinate laboratory testing and manufacturing partners. Its work covers complex generics, lifecycle extensions, stalled formulation programs and new chemical entities.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | Berkeley SKYDECK — Role not disclosedHabico Invest — Role not disclosedOxford Science Enterprises — Role not disclosed |